Unum Therapeutics' Series A Round

Unum Therapeutics raised a round of funding on October 21, 2014.

Unum Therapeutics is a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers. Unum develops combination cancer therapies using recent…

Articles about Unum Therapeutics' Series A Round: